Role of neutrophils in the pathogenesis of Post Kala-azar Dermal Leishmaniasis (PKDL)
Madhurima Roy,Ritika Sengupta,Bidhan Chandra Chakraborty,Uttara Chatterjee,Esther von Stebut,Paul M. Kaye,Mitali Chatterjee
DOI: https://doi.org/10.1371/journal.pntd.0012655
2024-11-28
PLoS Neglected Tropical Diseases
Abstract:Post Kala-azar Dermal Leishmaniasis (PKDL) is a dermal sequel of visceral leishmaniasis (VL), poses a significant threat to the success of ongoing kala-azar elimination program, due to its potential role in sustaining transmission cycles and complicating disease management strategies. In VL, neutrophils have been identified as the 'first line of defence', having multiple roles in disease pathogenesis, but their role in PKDL, if any, still remains elusive; presenting a critical gap in knowledge, and was the aim of this study. In a cohort of PKDL patients, CD66b + neutrophils were quantified in skin biopsies, followed by immunostaining of FFPE sections to identify activated neutrophils (CD66b + /CD64 + ) and degranulated (CD66b + /MPO + ), along with expression of neutrophil elastase (NE), matrix metalloprotease 9 (MMP9) and collagen I. Plasma levels of neutrophil chemo-attractants CXCL8/1/2/5, CCL2 and 20 and cytokines, (IL-6, IFN-γ, IL-4, IL-10, TNF-α, IL-17 and IL-22, 23) were evaluated by a multiplex assay, while lesional expression of IL-8, IL-10 and IL-17 was evaluated by immunohistochemistry. As compared to healthy individuals (control skin samples), PKDL cases at the lesional sites had an increased number of activated CD66b + neutrophils (positive for CD64 + , MPO + and NE + ). The plasma levels of neutrophil chemo-attractants, pro-inflammatory and regulatory cytokines were raised as was circulating and lesional IL-8, along with an enhanced lesional expression of IL-10 and IL-17A. An increase in circulatory and lesional MMP9 was accompanied by decreased collagen I, suggesting disintegration of matrix integrity. Taken together, in PKDL, activated neutrophils possibly contribute towards modulating the lesional landscape. Understanding this involvement of neutrophils in patients with PKDL, particularly in the absence of an animal model, could offer better understanding of the disease pathogenesis and provide insights into novel therapeutic strategies for the ongoing elimination program. Visceral leishmaniasis (VL), also known as kala-azar, is a fatal form of leishmaniasis caused by the digenetic parasite Leishmania donovani . In South Asia, around 10–20% of the cured VL cases develop a chronic dermal manifestation known as post-kala-azar dermal leishmaniasis (PKDL). Patients with PKDL serve as 'active disease reservoirs', perpetuating the transmission cycle and thereby pose a significant threat to the success of the ongoing kala-azar elimination program. Moreover, the absence of an animal model in PKDL poses a great challenge in elucidating the pathogenesis of the disease, thereby restricting studies exclusively to clinical cases. Neutrophils are recognized as crucial players in the initial phase of VL, acting as the 'first line of defence' and actively influence the outcome of infection, but their significance in PKDL has been overlooked, with previous research primarily focussing on macrophages and lymphocytes. This study addresses the critical gap in understanding the role of neutrophils in PKDL. This study revealed that neutrophils infiltrating at the lesional sites in PKDL played a functional role in modulating the disease pathology, shedding light on their involvement beyond the initial phase of infection. Conclusively, the findings in this study highlighted the importance of considering neutrophils as the 'new kid in the block' in PKDL immunology. In addition, this study contributed to a broader understanding of the disease pathogenesis by elucidating the extended roles of neutrophils in chronic phase of infection providing valuable insights that could potentiate targeted interventions, crucial for elimination of this debilitating neglected tropical disease.
tropical medicine,parasitology